日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitis

发现一种ITK和TRK激酶抑制剂,可用于治疗特应性皮炎。

Duffen, Jennifer L; Crouse, Kimberly K; Ji, Lin; Brault, Amy L; Ford, Kristen; Brooks, Jonathan; Jelinsky, Scott A; Li, Yizheng; Shin, Julia H; Zhao, Yajuan; Andreyeva, Tatyana; Hammerman, Katherine; Arnold, Christina; Sheldon, Richard T; Garren, Jeonifer; LaBarge, Wes; Resek, Anthony; Volmer, Jon; Bagley, Scott W; Casimiro-Garcia, Agustin; Chinigo, Gary M; Davoren, Jennifer E; Denny, Rajiah Aldrin; Drozda, Susan; Foley, Timothy L; Hicklin, Robert W; Liu, Shenping; Lovering, Frank E; Nedoma, Nicole L; Parikh, Mihir D; Strohbach, Joseph W; Trujillo, John I; Steyn, Stefanus J; Nocka, Karl; Hegen, Martin; Vincent, Fabien; Lee, Katherine L; Gerstenberger, Brian S; Primiano, Michael J

Inhibiting peptidylarginine deiminases (PAD1-4) by targeting a Ca(2+) dependent allosteric binding site.

通过靶向 Ca(2+) 依赖性变构结合位点来抑制肽基精氨酸脱亚胺酶 (PAD1-4)

Dakin Leslie A, Xing Li, Hall Justin, Ding Weidong, Vajdos Felix F, Pelker Jeffrey W, Ramsey Simeon, Balbo Paul, Sahasrabudhe Parag V, Banker Mary Ellen, Choi Won Young, Wright Stephen W, Chang Jeanne S, Curto John M, Davoren Jennifer E, Drozda Susan E, Fennell Kimberly F, Futatsugi Kentaro, Kortum Steve, Lee Katherine L, Liu Shenping, Lovering Frank, Nicki Jennifer A, Trujillo John I, Vincent Fabien, Schnute Mark E

Peptidylarginine Deiminase (PAD) Inhibitor Optimization through Displacement of a Trapped Water Molecule

通过置换被捕获的水分子来优化肽基精氨酸脱亚胺酶(PAD)抑制剂

Schnute, Mark E; Chinigo, Gary M; Futatsugi, Kentaro; Yamaguchi, Masaya; Bagley, Scott W; Banker, Mary Ellen; Chang, Jeanne S; Chen, Ming Z; Choi, Won Young; Corbett, Matthew S; Drozda, Susan E; Ebner, David C; Garcia-Irizarry, Carmen; Hicklin, Robert; Hoy, Susan; Jiao, Wenhua; Kortum, Steven; Lee, Katherine L; Limburg, David C; Lovering, Frank; Moreno, Antonio; Mousseau, James J; Pan, Senliang; Parikh, Mihir D; Pelker, Jeffrey W; Ramsey, Simeon; Reilly, Usa; Rescourio, Gwenaella; Schmitt, Daniel C; Simpson, Brittany; Skrzypek, Grzegorz J; Smaltz, Daniel J; Taylor, Alexandria P; Torella, Rubben; Trujillo, John I; Vajdos, Felix F; Wepy, James A; Wright, Stephen W; Blakemore, David C; Vincent, Fabien; Clerin, Valerie M

Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatment

调节性T细胞疗法治疗干燥综合征:从发病机制到靶向治疗

Lim, Zhi Feng Sherman; Hoi, Alberta Y; Vincent, Fabien B; Ooi, Joshua D; Morand, Eric F; Rischmueller, Maureen; Ting, Yi Tian

Evaluation of primary aldosteronism testing in hypertensive patients with SLE in a tertiary hospital

在一家三级医院对患有系统性红斑狼疮的高血压患者进行原发性醛固酮增多症检测的评估

Wong, Matthew; Hoi, Alberta Y; Kent, Joanna R; Fuller, Peter J; Yang, Jun; Vincent, Fabien B

Phenotypic drug discovery: recent successes, lessons learned and new directions

表型药物发现:近期成功案例、经验教训和未来方向

Vincent, Fabien; Nueda, Arsenio; Lee, Jonathan; Schenone, Monica; Prunotto, Marco; Mercola, Mark

Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis

系统性红斑狼疮患者I型干扰素状态:一项纵向分析

Northcott, Melissa; Jones, Sarah; Koelmeyer, Rachel; Bonin, Julie; Vincent, Fabien; Kandane-Rathnayake, Rangi; Hoi, Alberta; Morand, Eric

GILZ Regulates the Expression of Pro-Inflammatory Cytokines and Protects Against End-Organ Damage in a Model of Lupus

GILZ调节促炎细胞因子的表达,并在狼疮模型中保护终末器官免受损伤

Nataraja, Champa; Dankers, Wendy; Flynn, Jacqueline; Lee, Jacinta P W; Zhu, Wendy; Vincent, Fabien B; Gearing, Linden J; Ooi, Joshua; Pervin, Mehnaz; Cristofaro, Megan A; Sherlock, Rochelle; Hasnat, Md Abul; Harris, James; Morand, Eric F; Jones, Sarah A

Associations of metabolic syndrome in SLE

系统性红斑狼疮中代谢综合征的关联

Apostolopoulos, Diane; Vincent, Fabien; Hoi, Alberta; Morand, Eric

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus

血清可溶性Fas和Fas配体(FasL)与系统性红斑狼疮预后的相关性

Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F